Clinical Trial Update: Irinotecan and Temozolomide for Ewing Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating irinotecan and temozolomide for Ewing sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Ewing Sarcoma | Phase 2 | Status: UNKNOWN